ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 140,717
- Share change
- -49,108
- Total reported value
- $156,321
- Price per share
- $1.11
- Number of holders
- 10
- Value change
- -$71,544
- Number of buys
- 5
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 29273B302?
CUSIP 29273B302 identifies NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29273B302:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.9%
|
58,054
|
$82,436 | — | 30 Jun 2023 | |
| Michael Milos Thornton |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
34,139
|
$56,329 | — | 18 May 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
36,701
|
$52,115 | — | 30 Jun 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
2.7%
|
32,260
|
$45,168 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
26,551
|
$37,172 | — | 30 Jun 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.96%
|
11,343
|
$15,880 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.93%
|
10,994
|
$15,000 | — | 30 Jun 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.88%
|
10,495
|
$14,000 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.21%
|
2,493
|
$3,490 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
781
|
$1,094 | — | 30 Jun 2023 | |
| Worth Asset Management, LLC |
13F
|
Company |
—
class O/S missing
|
670
|
$938 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
103
|
$144 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
50
|
$70 | — | 30 Jun 2023 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q3 2023
As of 30 Sep 2023,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
140,717 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, NewEdge Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, Tower Research Capital LLC (TRC), VALLEY NATIONAL ADVISERS INC, JPMORGAN CHASE & CO, MORGAN STANLEY, BlackRock Inc., and WELLS FARGO & COMPANY/MN.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
11
Q3 2023 holders
10
Holder diff
-1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.